US Patent Issued to Perfuse Therapeutics on May 12 for "Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases" (North Carolina, California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,894, issued on May 12, was assigned to Perfuse Therapeutics Inc. (San Francisco).

"Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases" was invented by Cheng-Wen Lin (Cary, N.C.), Angela Dawn Glendenning (Raleigh, N.C.) and Sevgi Gurkan (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a biodegradable ocular implant comprising a biodegradable polymer containing a compound such as Edonentan, or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treatment of ocular diseases with the biodegradable ocular implant and methods of prepa...